EP1549291A4 - Injection formulation - Google Patents

Injection formulation

Info

Publication number: EP1549291A4
Authority: EP; European Patent Office
Prior art keywords: injection formulation; formulation; injection
Prior art date: 2002-05-16
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP03725918A

Other languages

German (de)

French (fr)

Other versions

EP1549291A1 (en

Inventor

Craig Robert Bunt

Colin Roger Ogle

Michael John Rathbone

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Interag

Original Assignee

Interag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-05-16

Filing date

2003-05-16

Publication date

2008-08-20

2003-05-16 Application filed by Interag filed Critical Interag

2005-07-06 Publication of EP1549291A1 publication Critical patent/EP1549291A1/en

2008-08-20 Publication of EP1549291A4 publication Critical patent/EP1549291A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/40—Cyclodextrins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Inorganic Chemistry (AREA)
Oncology (AREA)
Dermatology (AREA)
Communicable Diseases (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Oil, Petroleum & Natural Gas (AREA)
Tropical Medicine & Parasitology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP03725918A 2002-05-16 2003-05-16 Injection formulation Withdrawn EP1549291A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
NZ51899702A NZ518997A (en)	2002-05-16	2002-05-16	Injection formulation for parenteral administration of biodegradable implant for sustained release of active agent
NZ51899702		2002-05-16
PCT/NZ2003/000095 WO2003097009A1 (en)	2002-05-16	2003-05-16	Injection formulation

Publications (2)

Publication Number	Publication Date
EP1549291A1 EP1549291A1 (en)	2005-07-06
EP1549291A4 true EP1549291A4 (en)	2008-08-20

Family

ID=29546531

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP03725918A Withdrawn EP1549291A4 (en)	2002-05-16	2003-05-16	Injection formulation

Country Status (6)

Country	Link
EP (1)	EP1549291A4 (en)
JP (1)	JP2005538052A (en)
AU (1)	AU2003228174A1 (en)
CA (1)	CA2486133A1 (en)
NZ (1)	NZ518997A (en)
WO (1)	WO2003097009A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR20070104931A (en) *	2005-02-09	2007-10-29	마커사이트, 인코포레이티드	Formulations for ocular treatment
US8663639B2 (en)	2005-02-09	2014-03-04	Santen Pharmaceutical Co., Ltd.	Formulations for treating ocular diseases and conditions
JP5382328B2 (en) *	2009-06-23	2014-01-08	栗田工業株式会社	Leakage prevention material for metal electrolytic capacitors
JP5636640B2 (en) *	2009-06-23	2014-12-10	栗田工業株式会社	Absorbent for metal electrolytic capacitors
TWI480908B (en) *	2009-06-02	2015-04-11	Kurita Water Ind Ltd	Metal electrolytic capacitors and metal electrolytic capacitors with absorbent materials and leak-proof materials
JP5636637B2 (en) *	2009-06-02	2014-12-10	栗田工業株式会社	Metal electrolytic capacitor
JP5382327B2 (en) *	2009-06-02	2014-01-08	栗田工業株式会社	Metal electrolytic capacitor

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5902799A (en) *	1989-04-23	1999-05-11	The Trustees Of The University Of Pennsylvania	Methods of modulating tissue growth and regeneration
WO2000071079A2 (en) *	1999-05-21	2000-11-30	American Bioscience, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE0000730D0 (en) *	2000-03-06	2000-03-06	Scotia Holdings Plc	Lipid carrier
EP1267955B1 (en) *	2000-03-20	2006-05-31	Biosphere Medical, Inc.	Injectable microspheres for tissue construction
US6436424B1 (en) *	2000-03-20	2002-08-20	Biosphere Medical, Inc.	Injectable and swellable microspheres for dermal augmentation

2002
- 2002-05-16 NZ NZ51899702A patent/NZ518997A/en not_active IP Right Cessation
2003
- 2003-05-16 AU AU2003228174A patent/AU2003228174A1/en not_active Abandoned
- 2003-05-16 EP EP03725918A patent/EP1549291A4/en not_active Withdrawn
- 2003-05-16 JP JP2004505008A patent/JP2005538052A/en active Pending
- 2003-05-16 CA CA002486133A patent/CA2486133A1/en not_active Abandoned
- 2003-05-16 WO PCT/NZ2003/000095 patent/WO2003097009A1/en active Application Filing

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5902799A (en) *	1989-04-23	1999-05-11	The Trustees Of The University Of Pennsylvania	Methods of modulating tissue growth and regeneration
WO2000071079A2 (en) *	1999-05-21	2000-11-30	American Bioscience, Inc.	Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO03097009A1 *

Also Published As

Publication number	Publication date
CA2486133A1 (en)	2003-11-27
NZ518997A (en)	2004-12-24
AU2003228174A1 (en)	2003-12-02
EP1549291A1 (en)	2005-07-06
JP2005538052A (en)	2005-12-15
WO2003097009A1 (en)	2003-11-27

Legal Events

Date	Code	Title	Description
2005-05-20	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2005-07-06	17P	Request for examination filed	Effective date: 20041207
2005-07-06	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
2005-07-06	AX	Request for extension of the european patent	Extension state: AL LT LV MK
2005-09-07	DAX	Request for extension of the european patent (deleted)
2008-08-20	A4	Supplementary search report drawn up and despatched	Effective date: 20080717
2009-03-13	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-04-15	18D	Application deemed to be withdrawn	Effective date: 20081016

Publication	Publication Date	Title
GB2397767B (en)	2006-07-05	Injection device
GB0229384D0 (en)	2003-01-22	Injection device
GB0210123D0 (en)	2002-06-12	Injection device
AU2003256508A8 (en)	2004-02-02	Activation-based injection device
GB0211294D0 (en)	2002-06-26	Improvements relating to injection devices
EP1589901A4 (en)	2006-08-09	Intracutaneous injection
IL172597A0 (en)	2006-04-10	Injection device
GB0205066D0 (en)	2002-04-17	Improvements relating to injection devices
GB0319874D0 (en)	2003-09-24	Novel formulation
GB0207438D0 (en)	2002-05-08	Formulation
AU2003259457A8 (en)	2004-04-30	Auto-destructible syringe
GB0205504D0 (en)	2002-04-24	Formulation
GB0318448D0 (en)	2003-09-10	Formulation
GB0312195D0 (en)	2003-07-02	Formulation
EP1549291A4 (en)	2008-08-20	Injection formulation
GB0320522D0 (en)	2003-10-01	Formulation
GB0217285D0 (en)	2002-09-04	Syringes
GB0303876D0 (en)	2003-03-26	Formulation
EP1507542A4 (en)	2008-01-23	Anti-cancer formulation
GB0214147D0 (en)	2002-07-31	Formulations
GB0305560D0 (en)	2003-04-16	Fuel formulations
EP1693113A4 (en)	2009-11-04	Injection disperser
GB0213005D0 (en)	2002-07-17	Injection nozzle
GB0215589D0 (en)	2002-08-14	Formulation
GB0225040D0 (en)	2002-12-04	Formulation